Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.24 +0.18%   SPY: 134.83 +0.03%
Quote Spy OSIR NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Osiris Therapeutics (OSIR)

@ Feb-08
Click the portfolio to add OSIR:
Close [X]
+ Add OSIR to Portfolio
  
  Last Trade: $5.84 -0.06 (-1.02%)
  Volume: 30,280 91% of avg daily volume
       
  Avg Volume: 90,131
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 5.70 - 5.92
  Open: 5.92
  Previous Close: 5.90
  52-wk Range: 4.12 - 8.39
  Market Cap: 193.6M
  P/E: 13.4
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (0.0%)
Stem Cell Stocks (0.0%)
Spy OSIR

? Pro holders
? Member holders
? Items submitted
Additional OSIR resources



Customize Links
To see which Pros and tickerspy members own OSIR Sign up now
Latest OSIR Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Afternoon Spy: Markets Hold Ground Today
SWKS  GE  INTC  AAPL  NANO  IMPUY  C  CSCO  COF  OVTI  CHU  MXL  MTL  CUR  OSIR  CLWR  JKS  OGXPY  GM  NILSY  
Linked by tickerspy Newswire - June 07, 02:35PM from (www.tickerspy.com)
The markets were trading with solid gains Tuesday afternoon after the S&P lost 4.4% over the previous four trading  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Select Stem Cell Stocks Surge After Favorable Court Ruling
NBS  STEM  GERN  ASTM  PSTI  CUR  OSIR  ATHX  
Linked by tickerspy Newswire - May 02, 12:41PM from (www.tickerspy.com)
A ruling by federal appeals court last Friday allowing for continued government funding of human embryonic stem cell research  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
After Japanese Crisis, New Urgency to Develop Radiation Drugs
OSIR  
Linked by NYTimes - March 31, 03:53PM from (feeds.nytimes.com)
Experts say that progress has been made in developing treatments for radiation poisoning. But many obstacles remain.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Reports Third Quarter 2010 Financial Results
OSIR  
Linked by BusinessWire - November 05, 08:00AM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Announces Third Quarter 2010 Financial Results Conference Call
OSIR  
Linked by BusinessWire - November 01, 05:00PM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the quarter ended  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Did Dendreon Open Doors For Opexa Partnerships?
NBS  BTX  GERN  OPXA  DNDN  NVS  CUR  OSIR  
Linked by tickerspy Newswire - September 13, 02:10PM from (www.tickerspy.com)
Micro-cap stem cell research firm Opexa Therapeutics (OPXA) surged higher by 70% on Monday, ahead of the firm's presentation  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Investors Eye Stem Cell Shares Amid Court Dispute
GERN  ASTM  OPXA  CYTX  OSIR  ATHX  
Linked by tickerspy Newswire - August 26, 09:15AM from (www.tickerspy.com)
Earlier this week, U.S. District Judge Royce Lamberth hit the brakes an executive order aimed to remove "barriers to responsible  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Reports Second Quarter 2010 Financial Results
OSIR  
Linked by BusinessWire - August 06, 07:00AM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products to treat  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource